| 1. 马瑞旻，梁嘉俊，王瀚婧，张文馨，马重阳，杜宇琼.截断 逆 挽 方 调 控 PINK1 /Parkin 通 路 改 善 HepG2 细胞氧化应激损伤的研究.环球中医药.2025.第18卷第9期.1780-1786.CSCD |
| 2. 马瑞旻， 王瀚婧，张文馨，马重阳，张秋云，杜宇琼.截断逆挽方调控AMPK改善HepG2细胞线粒体损伤的机制.北京中医药大学学报.2025.48卷第2期.193-204.CSCD |
| 3. 张文馨.Bibliometric and visual analysisin the field of macrophages in Traditional Chinese Medicine from 2003 to 2023.Frontiers in Immunology.2025.2025 Apr 2？；16.1558926.SCI（含SCIE） |
| 4. QianlingYe1,2, HanjingWang1,2, Yue Chen1,2, Yihao Zheng1,2, Yuqiong Du1,2*,Chongyang Ma1,2* & Qiuyun Zhang.PANoptosis？like deathin acute？on？chronic liver failureinjury.Scientific Reports.2024.14（1）.392.SCI（含SCIE） |
| 5. Jiajun Liang1,2 , Xiaoyi Wei 3 , Weixin Hou4 , Hanjing Wang1,2 , Ruimin Ma1,2 , Yanbin Gao1,2* , Yuqiong Du1,2* and Qiuyun Zhang1,2* .Liver metabolomics reveals potential mechanism of？Jieduan-Niwan formula against？acute-on-chronic liver failure (ACLF) by？improving mitochondrial damage and？TCA cycle.Chinese Medicine.2023.18（1）.157.SCI（含SCIE） |
| 6. 林颖，杜宇琼，张子倩，张秋云，梁嘉俊，王瀚婧.基于数据挖掘探析钱英辨治肝硬化用药规律.中国中医药信息杂志.2023.30-06.54-58.CSCD |
| 7. J Liang, X Wei, W Hou, H Wang, Q Zhang, Y Gao, Y Du.Bioinformatics analyses of potential ACLF biological mechanisms and identification of immune-related hub genes and vital miRNAs..scientific reports.2022.Aug 18;12(1).14052.SCI（含SCIE） |
| 8. Chongyang Maa, Kai Yanb, Zisong Wangb, Qiuyun Zhanga, Lianyin Gaoa, Tian Xuc, Jiayang Said, Fafeng Chengc,and Yuqiong Dua.The association between hypertension and nonalcoholic fatty liver disease(NAFLD): literature evidence and systems biology analysis.Bioengineered.2021.12（1）.2187-2202.SCI（含SCIE） |
| 9. 吴梦丽 梁嘉俊 魏飞力 杨文龙 杜宇琼 张秋云.截断逆挽方含药血清对D-氨基半乳糖诱导 的人正常肝细胞 LO2 细胞增殖影响.环球中医药.2020.13（1）.23-28.CSCD |
| 10. Jiajun Liang ,1 Mengli Wu,1 Chen Bai,2 Chongyang Ma,1 Peng Fang,1 Weixin Hou,1Xiaoyi Wei,1 Qiuyun Zhang,1 and Yuqiong Du 1.Network Pharmacology Approach to Explore the PotentialMechanisms of Jieduan-Niwan Formula TreatingAcute-on-Chronic Liver Failure.Evidence-Based Complementary and Alternative Medicine.2020.1041307. 1041307.SCI（含SCIE） |
